CHRISTINE ERCOLINE: Open Payments
NPI 1912769589 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 15 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $237 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $86 |
| Novo Nordisk Inc | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Averitas Pharma Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, Wegovy, QUTENZA, FREESTYLE LIBRE 3, MOUNJARO, BREZTRI, Ozempic.
Industry payments across AZ — which companies pay providers there.
